Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
-
- Penson
- 作成者
収録刊行物
-
- Lancet
-
Lancet 376 245-,